Market Overview

Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc

Share:
Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
Related GILD
Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers
'Safe' NASDAQ Index Dividend Dog Gains Led By Western Digital, Mattel, & Gilead For February (Seeking Alpha)
Related C
Is The Rally In Bank Stocks Over?
Fast Money Traders Share Their Profit-Taking Candidates
Wells Fargo: Outperformer In The Long Run (Seeking Alpha)

On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. (NASDAQ: GILD) has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.

Cramer thinks Citigroup Inc (NYSE: C) was well prepared for the stress test, and he believes it is a buy at its current price.

Posted-In: Jim CramerBiotech CNBC Long Ideas Jim Cramer Media Trading Ideas General

 

Related Articles (GILD + C)

View Comments and Join the Discussion!